Information:
Error:
ID
20606
Description
Effect of Androgel on Type 2 Diabetic Males With Hypogonadism; ODM derived from: https://clinicaltrials.gov/show/NCT00350701
Link
https://clinicaltrials.gov/show/NCT00350701
Keywords
Versions (1)
- 3/6/17 3/6/17 -
Uploaded on
March 6, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus Type 2 NCT00350701
Eligibility Diabetes Mellitus Type 2 NCT00350701
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus Type 2 NCT00350701
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Gender | Age
Item
males with age 35-75 years inclusive.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Hypogonadism Evidence of | Blood testosterone free decreased
Item
evidence of hypogonadism: low free testosterone.
boolean
C0020619 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1096126 (UMLS CUI [2])
C0332120 (UMLS CUI [1,2])
C1096126 (UMLS CUI [2])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Anticholesteremic Agents Dose Stable | Blood Pressure Pharmaceutical Preparations | Multivitamin preparation
Item
people on stable doses of cholesterol lowering medications, blood pressure medications and multi-vitamins are allowed.
boolean
C0003277 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0005823 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0301532 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0005823 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0301532 (UMLS CUI [3])
Testosterone Replacement | Testosterone Maintenance Duration
Item
if currently on testosterone replacement,testosterone treatment will be held for 8 weeks.
boolean
C0039601 (UMLS CUI [1,1])
C0559956 (UMLS CUI [1,2])
C0039601 (UMLS CUI [2,1])
C0024501 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0559956 (UMLS CUI [1,2])
C0039601 (UMLS CUI [2,1])
C0024501 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Blood Pressure Controlled | Taking medication
Item
bp under control even if on medication.
boolean
C0005823 (UMLS CUI [1,1])
C2587213 (UMLS CUI [1,2])
C1290952 (UMLS CUI [2])
C2587213 (UMLS CUI [1,2])
C1290952 (UMLS CUI [2])
Event Coronary | Procedures on Coronary Arteries
Item
coronary event or procedure in previous past 4 wks.
boolean
C0441471 (UMLS CUI [1,1])
C1522318 (UMLS CUI [1,2])
C0869781 (UMLS CUI [2])
C1522318 (UMLS CUI [1,2])
C0869781 (UMLS CUI [2])
Raised prostate specific antigen
Item
high psa
boolean
C0178415 (UMLS CUI [1])
Prostate carcinoma
Item
h/o prostate cancer
boolean
C0600139 (UMLS CUI [1])
Liver disease | Kidney Disease
Item
hepatic or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0022658 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other concurrent clinical trial
boolean
C2348568 (UMLS CUI [1])
Life threatening illness | Heart Disease
Item
any other life- threatening , non cardiac disease.
boolean
C3846017 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0018799 (UMLS CUI [2])
Blood Pressure Uncontrolled
Item
uncontrolled bp
boolean
C0005823 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Hemoglobin increased
Item
high hemoglobin
boolean
C0549448 (UMLS CUI [1])
Investigational New Drugs | Therapies, Investigational
Item
use of investigational agent or therapeutic regimen within 30 days of study.
boolean
C0013230 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
C0949266 (UMLS CUI [2])